However, these agents were linked to an increased likelihood of procedure discontinuation, presumably due to aggravated gastric retention [22]
It just wasnt the outcome people were hoping for. UPDATE: November 27 9:10AM ET
You will not use, or allow others to use, our products for human or veterinary applications under any circumstances
Direct head-to-head comparisons are not possible because the trials differed in duration, population and study design, but reporting outcomes side-by-side provides context
Although GLP-1 RAs have been on the market for 20 years, its also possible new risks may emerge as more people take GLP-1 RAs over many years
are not in accordance with the data, presented by Xu et al., on increased circulating levels of GLP-1 in GHS-R1A null mice